80 related articles for article (PubMed ID: 27662249)
1. A New Staple: Peptide-Targeted Covalent Inhibitors.
Leverson JD
Cell Chem Biol; 2016 Sep; 23(9):1043-1044. PubMed ID: 27662249
[TBL] [Abstract][Full Text] [Related]
2. Selective Covalent Targeting of Anti-Apoptotic BFL-1 by Cysteine-Reactive Stapled Peptide Inhibitors.
Huhn AJ; Guerra RM; Harvey EP; Bird GH; Walensky LD
Cell Chem Biol; 2016 Sep; 23(9):1123-1134. PubMed ID: 27617850
[TBL] [Abstract][Full Text] [Related]
3. Selective Covalent Targeting of Anti-apoptotic BFL-1 by a Sulfonium-Tethered Peptide.
Liu N; Wang D; Lian C; Zhao R; Tu L; Zhang Y; Liu J; Zhu H; Yu M; Wan C; Li D; Li S; Yin F; Li Z
Chembiochem; 2021 Jan; 22(2):340-344. PubMed ID: 32790056
[TBL] [Abstract][Full Text] [Related]
4. N-locking stabilization of covalent helical peptides: Application to Bfl-1 antagonists.
Baggio C; Udompholkul P; Gambini L; Jossart J; Salem AF; Håkansson M; Perry JJP; Pellecchia M
Chem Biol Drug Des; 2020 Apr; 95(4):412-426. PubMed ID: 31898401
[TBL] [Abstract][Full Text] [Related]
5. A simple method for developing lysine targeted covalent protein reagents.
Gabizon R; Tivon B; Reddi RN; van den Oetelaar MCM; Amartely H; Cossar PJ; Ottmann C; London N
Nat Commun; 2023 Dec; 14(1):7933. PubMed ID: 38040731
[TBL] [Abstract][Full Text] [Related]
6. Relationship between helix stability and binding affinities: molecular dynamics simulations of Bfl-1/A1-binding pro-apoptotic BH3 peptide helices in explicit solvent.
Modi V; Lama D; Sankararamakrishnan R
J Biomol Struct Dyn; 2013; 31(1):65-77. PubMed ID: 22803956
[TBL] [Abstract][Full Text] [Related]
7. Peptide-Based Covalent Inhibitors Bearing Mild Electrophiles to Target a Conserved His Residue of the Bacterial Sliding Clamp.
Compain G; Monsarrat C; Blagojevic J; Brillet K; Dumas P; Hammann P; Kuhn L; Martiel I; Engilberge S; Oliéric V; Wolff P; Burnouf DY; Wagner J; Guichard G
JACS Au; 2024 Feb; 4(2):432-440. PubMed ID: 38425897
[TBL] [Abstract][Full Text] [Related]
8. Iterative optimization yields Mcl-1-targeting stapled peptides with selective cytotoxicity to Mcl-1-dependent cancer cells.
Rezaei Araghi R; Bird GH; Ryan JA; Jenson JM; Godes M; Pritz JR; Grant RA; Letai A; Walensky LD; Keating AE
Proc Natl Acad Sci U S A; 2018 Jan; 115(5):E886-E895. PubMed ID: 29339518
[TBL] [Abstract][Full Text] [Related]
9. Covalent Enzyme Inhibition through Fluorosulfate Modification of a Noncatalytic Serine Residue.
Fadeyi OO; Hoth LR; Choi C; Feng X; Gopalsamy A; Hett EC; Kyne RE; Robinson RP; Jones LH
ACS Chem Biol; 2017 Aug; 12(8):2015-2020. PubMed ID: 28718624
[TBL] [Abstract][Full Text] [Related]
10. Characterization of peptide aptamers targeting Bfl-1 anti-apoptotic protein.
Brien G; Debaud AL; Bickle M; Trescol-Biemont MC; Moncorge O; Colas P; Bonnefoy-Berard N
Biochemistry; 2011 Jun; 50(23):5120-9. PubMed ID: 21563784
[TBL] [Abstract][Full Text] [Related]
11. hBfl-1/hNOXA Interaction Studies Provide New Insights on the Role of Bfl-1 in Cancer Cell Resistance and for the Design of Novel Anticancer Agents.
Barile E; Marconi GD; De SK; Baggio C; Gambini L; Salem AF; Kashyap MK; Castro JE; Kipps TJ; Pellecchia M
ACS Chem Biol; 2017 Feb; 12(2):444-455. PubMed ID: 28026162
[TBL] [Abstract][Full Text] [Related]
12. Exploitation of the Ornithine Effect Enhances Characterization of Stapled and Cyclic Peptides.
Crittenden CM; Parker WR; Jenner ZB; Bruns KA; Akin LD; McGee WM; Ciccimaro E; Brodbelt JS
J Am Soc Mass Spectrom; 2016 May; 27(5):856-63. PubMed ID: 26864791
[TBL] [Abstract][Full Text] [Related]
13. Beyond cysteine: recent developments in the area of targeted covalent inhibition.
Mukherjee H; Grimster NP
Curr Opin Chem Biol; 2018 Jun; 44():30-38. PubMed ID: 29857316
[TBL] [Abstract][Full Text] [Related]
14. The amino acid sequence around the active-site cysteine and histidine residues, and the buried cysteine residue in ficin.
Husain SS; Lowe G
Biochem J; 1970 Apr; 117(2):333-40. PubMed ID: 5420043
[TBL] [Abstract][Full Text] [Related]
15. Chemical Cleavage of an Asp-Cys Sequence Allows Efficient Production of Recombinant Peptides with an N-Terminal Cysteine Residue.
Pane K; Verrillo M; Avitabile A; Pizzo E; Varcamonti M; Zanfardino A; Di Maro A; Rega C; Amoresano A; Izzo V; Di Donato A; Cafaro V; Notomista E
Bioconjug Chem; 2018 Apr; 29(4):1373-1383. PubMed ID: 29528625
[TBL] [Abstract][Full Text] [Related]
16. Binding affinity of pro-apoptotic BH3 peptides for the anti-apoptotic Mcl-1 and A1 proteins: Molecular dynamics simulations of Mcl-1 and A1 in complex with six different BH3 peptides.
Modi V; Sankararamakrishnan R
J Mol Graph Model; 2017 May; 73():115-128. PubMed ID: 28279820
[TBL] [Abstract][Full Text] [Related]
17. Cysteinome: The first comprehensive database for proteins with targetable cysteine and their covalent inhibitors.
Wu S; Luo Howard H; Wang H; Zhao W; Hu Q; Yang Y
Biochem Biophys Res Commun; 2016 Sep; 478(3):1268-73. PubMed ID: 27553277
[TBL] [Abstract][Full Text] [Related]
18. Deciphering the crucial residues involved in heterodimerization of Bak peptide and anti-apoptotic proteins for apoptosis.
Marimuthu P; Singaravelu K
J Biomol Struct Dyn; 2018 May; 36(6):1637-1648. PubMed ID: 28511583
[TBL] [Abstract][Full Text] [Related]
19. Assessing the Efficacy of Mdm2/Mdm4-Inhibiting Stapled Peptides Using Cellular Thermal Shift Assays.
Tan BX; Brown CJ; Ferrer FJ; Yuen TY; Quah ST; Chan BH; Jansson AE; Teo HL; Nordlund P; Lane DP
Sci Rep; 2015 Jul; 5():12116. PubMed ID: 26159518
[TBL] [Abstract][Full Text] [Related]
20. Identification of Small Inhibitory Molecules Targeting the Bfl-1 Anti-Apoptotic Protein That Alleviates Resistance to ABT-737.
Mathieu AL; Sperandio O; Pottiez V; Balzarin S; Herlédan A; Elkaïm JO; Fogeron ML; Piveteau C; Dassonneville S; Deprez B; Villoutreix BO; Bonnefoy N; Leroux F
J Biomol Screen; 2014 Aug; 19(7):1035-46. PubMed ID: 24809353
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
